To verify its role in LUAD, several public datasets confirmed that low levels of LSAMP conferred tumor invasiveness, nodal metastasis, and advanced tumor stages as well as poor clinical outcomes with short survival time. This evidence concerns the gene LSAMP and neoplasm.